Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Assembly Biosciences Reports Interim Results From Phase 1b Clinical Study Of ABI-5366, showing 94% Reduction In HSV-2 Shedding Rate And 98% Reduction In High Viral Load Shedding Rate

Author: Benzinga Newsdesk | August 08, 2025 08:09am

Posted In: ASMB